Solid Tumors
A Phase 1b/2, Multicenter, Open-label Basket Study Evaluating the Safety and Efficacy of Bemarituzumab Monotherapy in Solid Tumors with FGFR2b Overexpression (FORTITUDE-301) (20210104)
- Details
ClinicalTrials.gov ID:
NCT05325866
Diagnosis Type:
NA
USOR Number:
- Address
1700 S Potomac Street
Aurora, CO 80012
P: (303) 418-7659